Vitamin D Treatment for a 7-Year-Old with Deficiency
For a 7-year-old child with documented vitamin D deficiency, treat with 2,000 IU of vitamin D3 daily for 12 weeks (or alternatively 50,000 IU every other week for 12 weeks), followed by maintenance therapy of 600 IU daily. 1
Initial Treatment Phase (Weeks 1-12)
Choose one of these evidence-based regimens:
- 2,000 IU of vitamin D3 orally daily for 12 weeks, OR 1
- 50,000 IU of vitamin D3 every other week for 12 weeks 1
Cholecalciferol (vitamin D3) is strongly preferred over ergocalciferol (vitamin D2) because it has higher bioefficacy and more effectively raises serum 25(OH)D levels. 1
The goal is to achieve a serum 25(OH)D level above 20 ng/mL (50 nmol/L). 1 At age 7, the child falls well within the safety margin, as the upper tolerable limit for ages 4-8 years is 3,000 IU/day—well above the recommended treatment dose. 1
Essential Concurrent Calcium Supplementation
Provide 250-500 mg/day of elemental calcium during the entire 12-week treatment period. 1 This is critical because:
- Vitamin D increases calcium absorption, and adequate calcium prevents hypocalcemia 1
- Children with elevated PTH or low ionized calcium at baseline are particularly vulnerable without calcium co-supplementation 1
Monitoring Strategy
Recheck serum 25(OH)D levels after the 12-week treatment period to confirm normalization (target >20 ng/mL). 1 If levels have normalized, proceed to maintenance therapy. 1
Once normalized, monitor 25(OH)D levels every 6-12 months, especially during winter months when sun exposure is limited. 1
Maintenance Phase (After Week 12)
After achieving normal vitamin D levels, continue with 600 IU of vitamin D3 daily indefinitely. 1 This maintenance dose is recommended by the American Academy of Pediatrics, ESPGHAN, and the Institute of Medicine for all children ages 1-18 years. 1
Additional Baseline Assessments
Before or at treatment initiation, consider checking:
- Serum calcium, phosphorus, alkaline phosphatase, and parathyroid hormone (PTH) to assess for metabolic bone disease or rickets 1
- Physical examination for signs of rickets (bowing of legs, rachitic rosary, wrist widening), as severe deficiency may already have caused clinical manifestations 1
Critical Pitfalls to Avoid
Do not use active vitamin D analogs (calcitriol, alfacalcidol, doxercalciferol, paricalcitol) to treat nutritional vitamin D deficiency—these are reserved for advanced chronic kidney disease, not simple nutritional deficiency. 1
Ensure adherence to the full 12-week treatment regimen. Inconsistent supplementation is a common cause of treatment failure. 1 The alternative every-other-week dosing (50,000 IU) may improve adherence in families who struggle with daily medication administration. 1
Do not exceed recommended doses. While vitamin D toxicity is rare at therapeutic doses, serum concentrations >375 nmol/L are associated with acute hypercalcemia and hyperphosphatemia. 1 The treatment dose of 2,000 IU/day remains well below the 3,000 IU/day upper limit for this age group. 1
Monitor for hypercalcemia if using concurrent calcium supplementation, particularly if the child has underlying conditions affecting calcium metabolism. 1
Special Considerations
If the child has chronic kidney disease, malabsorption disorders (celiac disease, inflammatory bowel disease, cystic fibrosis), or nephrotic syndrome, higher or more frequent supplementation may be needed, and closer monitoring of calcium, PTH, and 25(OH)D is essential. 1
For children with severe bone deformities suggestive of rickets, evaluate for secondary hyperparathyroidism and consider orthopedic consultation if deformities are severe enough to potentially require surgical intervention after metabolic correction. 1